Page 2 - Fda Guidance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Guidance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Guidance Today - Breaking & Trending Today

Update On Xbrane's Ranibizumab Application - Life Sciences, Biotechnology & Nanotechnology

Published: July 8, 2022

In May 2022, Xbrane announced that it had withdrawn its biologics license application (BLA) for its ranibizumab biosimilar of LUCENTIS®. On July 4, 2022, Xbrane announced that based on comments...

Source: mondaq.com

Related Topics:

United StatesFoley LardnerBuchanan Ingersoll RooneyAkin Gump Strauss Hauer FeldHuman ServicesFoley HoagThompson CoburnSupreme CourtLife SciencesPublic Health EmergencyAnti Kickback StatuteSocial Security ActBiosimilars NewsFda GuidanceLife SciencesIotechnology Amp Nanotechnology